Comparison of Elaeagnus angustifolia L. extract and quercetin on mouse model of knee osteoarthritis
Osteoarthritis (OA) is the most commonly observed arthritic disease causing severe pain and impairing patient's quality of life. This study aimed to investigate and compare the effect of Elaeagnus angustifolia extract and quercetin on the mouse model of ...
Mitra Heydari Nasrabadi +3 more
doaj +1 more source
The aim of the research. To assess the influence of polymorphisms of the matrix metalloproteinase genes — 2 (rs2285053), — 3 (rs3025058), and — 13 (rs2252070) on the development of coronary atherosclerosis in patients with primary osteoarthritis ...
O. O. Portyannikova +3 more
doaj +1 more source
Matrix metalloproteinase 13, a new target for therapy in Alzheimer's disease. [PDF]
Alzheimer's disease (AD), the most common neurodegenerative disorder, affects millions of people worldwide. In a recent publication, Guo-Jun Chen and colleagues highlight the role of matrix metalloproteinase (MMP) 13 (also called Collagenase 3) in AD pathogenesis through regulating BACE1, 1 a rate-limiting enzyme for β-amyloid (Aβ ...
Paumier JM, Thinakaran G.
europepmc +3 more sources
The expression of matrix metalloproteinase-13 (MMP-13) on xenograft and PRF in bone regeneration
Objective: inflammation may play a role in bone loss by altering the bone remodelling process, favouring bone resorption by osteoclasts over bone synthesis by osteoblasts.
Eka Fitria Augustina +2 more
doaj +1 more source
Matrix Metalloproteinase 13 Inhibitors for Modulation of Osteoclastogenesis: Enhancement of Solubility and Stability. [PDF]
AbstractMatrix metalloproteinase 13 (MMP‐13) activity has been correlated to breast cancer bone metastasis. It has been proposed that MMP‐13 contributes to bone metastasis through the promotion of osteoclastogenesis. To explore the mechanisms of MMP‐13 action, we previously described a highly efficacious and selective MMP‐13 inhibitor, RF036 ...
Knapinska AM +7 more
europepmc +3 more sources
Characterization of an exosite binding inhibitor of matrix metalloproteinase 13 [PDF]
AbstractMatrix metalloproteinase 13 (MMP13) is a key enzyme implicated in the degradation of the extracellular matrix in osteoarthritis. Clinical administration of broad spectrum MMP inhibitors such as marimastat has been implicated in severe musculo‐skeletal side effects. Consequently, research has been focused on designing inhibitors that selectively
Lata T, Gooljarsingh +6 more
openaire +2 more sources
Background and Aims Gene polymorphisms are responsible for at least part of the variation in caries susceptibility despite similar environmental factors.
Ebrahim Miri‐Moghaddam +4 more
doaj +1 more source
Targeting matrix metalloproteinase‐13 in bronchial epithelial repair [PDF]
AbstractBackgroundViral infection of the bronchial epithelium disrupts the barrier properties of the epithelium in healthy individuals and those with lung disease. Repair of the bronchial epithelium is dependent of the formation of a provisional fibrin matrix and migration of epithelial cells to cover denuded areas, followed by proliferation and ...
Christopher Howell +2 more
openaire +2 more sources
Evaluation of the Effect of Phytocomplex on Chondroprotective Biomarkers in an Experimental Model of Osteoarthritis in Rats [PDF]
Osteoarthritis (OA) is most prevalent joint disease and major contributor to non-fatal burden in India, with prevalence rates of 22% - 39%. The use of conventional medication can be associated with insufficient clinical management and serious side ...
Shridhar PANDYA +5 more
doaj +1 more source
Matrix metalloproteinases at key junctions in the pathomechanism of stroke [PDF]
Matrix metalloproteinases play a crucial role in the remodelling of the extracellular matrix through direct degradation of its structural proteins and control of extracellular signaling.
Kolev, Kraszimir +5 more
core +1 more source

